These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 2480289
1. Supportive haemotherapy in bone marrow transplantation. Mayr WR. Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):455-8. PubMed ID: 2480289 [Abstract] [Full Text] [Related]
2. The impact of the HLA-system in clinical medicine. van Rood JJ. Schweiz Med Wochenschr; 1993 Jan 23; 123(3):85-92. PubMed ID: 8426953 [Abstract] [Full Text] [Related]
3. Human histocompatibility antigens (HLA). Kumar R, Mittal KK. Indian Pediatr; 1983 Oct 23; 20(10):763-70. PubMed ID: 6373600 [No Abstract] [Full Text] [Related]
4. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets. Levy L, Woodfield DG. N Z Med J; 1984 Oct 24; 97(766):719-21. PubMed ID: 6595558 [Abstract] [Full Text] [Related]
5. Platelet transfusions in 75 patients undergoing autologous bone marrow transplantation. Lund BV, Madsen M. Transplant Proc; 1994 Jun 24; 26(3):1825. PubMed ID: 8030156 [No Abstract] [Full Text] [Related]
8. Laboratory procedures used to select an unrelated HLA matched bone marrow donor. van Leeuwen A, Oudshoorn M, Schreuder IM, Giphart MJ, Claas FH, van Rood JJ. Bone Marrow Transplant; 1993 Jun 24; 11 Suppl 1():13-6. PubMed ID: 8448537 [Abstract] [Full Text] [Related]
9. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients. Duqesnoy RJ. Prog Clin Biol Res; 1978 Jun 24; 28():229-43. PubMed ID: 88057 [No Abstract] [Full Text] [Related]
10. [Transplantation immunology in allogeneic bone marrow transplantation. The significance of HLA-tissue crossmatching between donors and recipients]. Egeland T, Thorsby E. Tidsskr Nor Laegeforen; 1994 Jan 30; 114(3):319-22. PubMed ID: 8191429 [Abstract] [Full Text] [Related]
13. [The Tübingen concept of transfusion medical care in bone marrow transplants]. Wernet D, Schnaidt M, Mayer G, Schneider W. Beitr Infusionther Klin Ernahr; 1987 Jul 30; 18():123-7. PubMed ID: 3326581 [No Abstract] [Full Text] [Related]
14. Sensitization by platelet transfusion. Brand A. Schweiz Med Wochenschr; 1991 Mar 30; 121(13):467-9. PubMed ID: 2031162 [Abstract] [Full Text] [Related]
15. [Importance of class-III and GLO alleles in the selection of HLA-identical bone marrow donors]. Wölpl A, Goldmann SF, Eiermann T, Arnold R. Beitr Infusionther Klin Ernahr; 1987 Mar 30; 18():326-8. PubMed ID: 3326591 [No Abstract] [Full Text] [Related]
16. Platelet supportive care: immunological and clinical aspects. Brand A, van Leeuwen A, Niterink A, Langerak J, Eernisse JG, van Rood JJ. Neth J Med; 1979 Mar 30; 22(4):133-7. PubMed ID: 481651 [No Abstract] [Full Text] [Related]
19. Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. Taaning E, Jacobsen N. Transplant Proc; 1994 Jun 30; 26(3):1826. PubMed ID: 8030157 [No Abstract] [Full Text] [Related]